Fund overlap
Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund
Fund A
Nippon India Pharma Fund
Nippon India Pharma Fund - Direct Plan - IDCW Option
Open Ended Schemes(Equity Schemes - Sectoral Fund) · Nippon India Mutual Fund
Fund B
HDFC Pharma and Healthcare Fund
HDFC Pharma and Healthcare Fund - Direct Plan - IDCW Option
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic) · HDFC Mutual Fund
Overlap
30.0%
- Shared holdings
- 16
- Holdings in A
- 38
- Holdings in B
- 39
Overlap measures how closely the two portfolios match, holding by holding and weight by weight, using each fund's latest disclosed holdings. 100% would mean the same holdings at the same weights.
Shared holdings
The 10 largest of 16 shared holdings, ordered by the smaller of the two weights.
| Holding | Nippon India Pharma Fund | HDFC Pharma and Healthcare Fund |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.71% | 8.28% |
| Divi's Laboratories Limited | 7.10% | 9.39% |
| Cipla Limited | 6.01% | 4.15% |
| Apollo Hospitals Enterprise Limited | 4.89% | 3.69% |
| Lupin Limited | 6.17% | 3.55% |
| Dr. Reddy's Laboratories Limited | 5.45% | 3.19% |
| IPCA Laboratories Limited | 2.87% | 2.98% |
| Max Healthcare Institute Limited | 2.70% | 3.61% |
| Vijaya Diagnostic Centre Limited | 2.62% | 2.00% |
| Alkem Laboratories Limited | 1.82% | 4.64% |
Data as of 30 Sept 2026
Method: weighted Jaccard
Weighted Jaccard adds up the smaller weight of every holding across both funds and divides by the sum of the larger weights.